Literature DB >> 25695407

Molecular Mechanisms of Interaction Between Human Immune Cells and Far Eastern Tick-Borne Encephalitis Virus Strains.

Natalya V Krylova1, Tatiana P Smolina1, Galina N Leonova1.   

Abstract

Although studies have established that immune mechanisms are important in controlling tick-borne encephalitis virus (TBEV) infection, the interactions of different TBEV strains with cells of innate and adaptive immunity are not well understood. In this study, the ability of two Far Eastern subtype TBEV strains (Dal'negorsk and Primorye-183) with various degrees of pathogenicity for humans to modulate the expression of membrane molecules differently on human immune cells were investigated using a whole-blood flow cytometry-based assay. The whole-blood samples (from 10 healthy donors) were infected with TBEV strains and analyzed for the virus binding to the blood cells, as well as expression of adhesion (CD11b and ICAM-1) and activation (CD69, CD25, CD95) molecules on the surfaces of monocytes, granulocytes, natural killer (NK) cells, and T-lymphocytes (CD4+, CD8+) at selected times (3, 6, and 24 h post-infection). It was found that the highly pathogenic Dal'negorsk strain penetrated rapidly and was actively replicated in the blood cells, inducing downregulation of CD11b, ICAM-1, and CD69 on monocytes and a significant decrease of NK cells expressing CD69, CD25, CD95, and CD8 T-lymphocytes expressing CD69 compared with the mock-infected cells. The nonpathogenic Primorye-183 strain penetrated slowly and was replicated in the blood cells, but caused a significant increase in the adhesion and activation of molecule expression to trigger innate defense mechanisms and enable the rapid elimination of the virus from the organism. Thus, TBEV-induced activation or suppression of adhesion and activation receptors expression form an essential part of fundamental virus properties, that is, virulence and pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25695407      PMCID: PMC4486442          DOI: 10.1089/vim.2014.0083

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  51 in total

1.  Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-alpha.

Authors:  Fabiola Atzeni; Monica Schena; Anna Maria Ongari; Maria Carrabba; Paola Bonara; Francesca Minonzio; Franco Capsoni
Journal:  Cell Immunol       Date:  2002-11       Impact factor: 4.868

Review 2.  Evasion of innate and adaptive immunity by flaviviruses.

Authors:  Michael S Diamond
Journal:  Immunol Cell Biol       Date:  2003-06       Impact factor: 5.126

Review 3.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia.

Authors:  M Ecker; S L Allison; T Meixner; F X Heinz
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

Review 5.  CD69 and regulation of the immune function.

Authors:  R Marzio; J Mauël; S Betz-Corradin
Journal:  Immunopharmacol Immunotoxicol       Date:  1999-08       Impact factor: 2.730

6.  Identification of genetic determinants of a tick-borne flavivirus associated with host-specific adaptation and pathogenicity.

Authors:  Dana N Mitzel; Sonja M Best; Max F Masnick; Stephen F Porcella; James B Wolfinbarger; Marshall E Bloom
Journal:  Virology       Date:  2008-09-26       Impact factor: 3.616

7.  Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections.

Authors:  V V Vargin; B F Semenov
Journal:  Acta Virol       Date:  1986-07       Impact factor: 1.162

8.  A paradoxical role for neutrophils in the pathogenesis of West Nile virus.

Authors:  Fengwei Bai; Kok-Fai Kong; Jianfeng Dai; Feng Qian; Lin Zhang; Charles R Brown; Erol Fikrig; Ruth R Montgomery
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

9.  Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells.

Authors:  Daniel Růžek; Jiří Salát; Sunit K Singh; Jan Kopecký
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

Review 10.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

View more
  5 in total

1.  Exome-wide search and functional annotation of genes associated in patients with severe tick-borne encephalitis in a Russian population.

Authors:  Elena V Ignatieva; Andrey A Yurchenko; Mikhail I Voevoda; Nikolay S Yudin
Journal:  BMC Med Genomics       Date:  2019-05-24       Impact factor: 3.063

2.  A database of human genes and a gene network involved in response to tick-borne encephalitis virus infection.

Authors:  Elena V Ignatieva; Alexander V Igoshin; Nikolay S Yudin
Journal:  BMC Evol Biol       Date:  2017-12-28       Impact factor: 3.260

3.  In Vivo Characterization of Tick-Borne Encephalitis Virus in Bank Voles (Myodes glareolus).

Authors:  Anna Michelitsch; Birke Andrea Tews; Christine Klaus; Malena Bestehorn-Willmann; Gerhard Dobler; Martin Beer; Kerstin Wernike
Journal:  Viruses       Date:  2019-11-15       Impact factor: 5.048

4.  In Vitro Characterization of the Innate Immune Pathways Engaged by Live and Inactivated Tick-Borne Encephalitis Virus.

Authors:  Aurora Signorazzi; Jeroen L A Pennings; Marilena P Etna; Malou Noya; Eliana M Coccia; Anke Huckriede
Journal:  Vaccines (Basel)       Date:  2021-06-17

5.  Zika Virus Infection Preferentially Counterbalances Human Peripheral Monocyte and/or NK Cell Activity.

Authors:  Fok-Moon Lum; David Lee; Tze-Kwang Chua; Jeslin J L Tan; Cheryl Y P Lee; Xuan Liu; Yongxiang Fang; Bernett Lee; Wearn-Xin Yee; Natasha Y Rickett; Po-Ying Chia; Vanessa Lim; Yee-Sin Leo; David A Matthews; Julian A Hiscox; Lisa F P Ng
Journal:  mSphere       Date:  2018-03-28       Impact factor: 4.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.